For the study, researchers compared 1,238 colorectal cancer patients to 1,239 health patients. Those with the highest levels of HDL cholesterol and apolipoprotein A had a lower risk of developing colon cancer. Specifically, for every 16.6 mg/dL HDL increase and 32 mg/dL apoA increase, colon cancer risk was cut by 22 percent and 18 percent, respectively, according to the news report.
Read the news report about HDL’s impact on colon cancer.
Read other coverage about colorectal cancer:
– Prognostic Test Gets CLIA Approval for Assessing Risk of Recurring CRC
– Study: GoLytely More Effective Bowel Prep Than MiraLAX
– Researchers Say Colonoscopy Needs More Widespread Use
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.